FBTAX vs. FHCCX
Compare and contrast key facts about Fidelity Advisor Biotechnology Fund Class A (FBTAX) and Fidelity Advisor Health Care Fund Class C (FHCCX).
FBTAX is managed by Fidelity. It was launched on Dec 27, 2000. FHCCX is managed by Fidelity. It was launched on Nov 3, 1997.
Performance
FBTAX vs. FHCCX - Performance Comparison
Loading graphics...
FBTAX vs. FHCCX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FBTAX Fidelity Advisor Biotechnology Fund Class A | 2.24% | 39.54% | 5.37% | 10.70% | -7.95% | -3.10% | 32.17% | 25.74% | -3.86% | 25.80% |
FHCCX Fidelity Advisor Health Care Fund Class C | -6.24% | -5.49% | 3.20% | 3.02% | -13.72% | 10.43% | 20.15% | 26.96% | 6.37% | 23.12% |
Returns By Period
In the year-to-date period, FBTAX achieves a 2.24% return, which is significantly higher than FHCCX's -6.24% return. Over the past 10 years, FBTAX has outperformed FHCCX with an annualized return of 11.86%, while FHCCX has yielded a comparatively lower 5.98% annualized return.
FBTAX
- 1D
- 5.08%
- 1M
- -0.75%
- YTD
- 2.24%
- 6M
- 15.54%
- 1Y
- 55.40%
- 3Y*
- 20.44%
- 5Y*
- 8.92%
- 10Y*
- 11.86%
FHCCX
- 1D
- 3.94%
- 1M
- -5.40%
- YTD
- -6.24%
- 6M
- -14.50%
- 1Y
- -9.01%
- 3Y*
- -2.07%
- 5Y*
- -2.42%
- 10Y*
- 5.98%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBTAX vs. FHCCX - Expense Ratio Comparison
FBTAX has a 1.00% expense ratio, which is lower than FHCCX's 1.72% expense ratio.
Return for Risk
FBTAX vs. FHCCX — Risk / Return Rank
FBTAX
FHCCX
FBTAX vs. FHCCX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class A (FBTAX) and Fidelity Advisor Health Care Fund Class C (FHCCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBTAX | FHCCX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.94 | -0.40 | +2.34 |
Sortino ratioReturn per unit of downside risk | 2.53 | -0.34 | +2.87 |
Omega ratioGain probability vs. loss probability | 1.33 | 0.94 | +0.39 |
Calmar ratioReturn relative to maximum drawdown | 3.16 | -0.43 | +3.58 |
Martin ratioReturn relative to average drawdown | 12.63 | -1.05 | +13.68 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FBTAX | FHCCX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.94 | -0.40 | +2.34 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.38 | -0.13 | +0.51 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.48 | 0.31 | +0.18 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.31 | 0.46 | -0.15 |
Correlation
The correlation between FBTAX and FHCCX is 0.83, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
FBTAX vs. FHCCX - Dividend Comparison
FBTAX's dividend yield for the trailing twelve months is around 1.42%, while FHCCX has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBTAX Fidelity Advisor Biotechnology Fund Class A | 1.42% | 1.45% | 6.00% | 1.15% | 0.00% | 20.12% | 8.37% | 6.77% | 2.50% | 0.00% | 0.00% | 5.36% |
FHCCX Fidelity Advisor Health Care Fund Class C | 0.00% | 0.00% | 17.59% | 0.00% | 0.00% | 8.32% | 6.85% | 0.41% | 6.43% | 0.00% | 0.00% | 7.84% |
Drawdowns
FBTAX vs. FHCCX - Drawdown Comparison
The maximum FBTAX drawdown since its inception was -63.55%, which is greater than FHCCX's maximum drawdown of -45.28%. Use the drawdown chart below to compare losses from any high point for FBTAX and FHCCX.
Loading graphics...
Drawdown Indicators
| FBTAX | FHCCX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.55% | -45.28% | -18.27% |
Max Drawdown (1Y)Largest decline over 1 year | -13.60% | -27.25% | +13.65% |
Max Drawdown (5Y)Largest decline over 5 years | -36.51% | -29.67% | -6.84% |
Max Drawdown (10Y)Largest decline over 10 years | -38.82% | -29.67% | -9.15% |
Current DrawdownCurrent decline from peak | -2.54% | -24.39% | +21.85% |
Average DrawdownAverage peak-to-trough decline | -21.34% | -10.12% | -11.22% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.71% | 11.03% | -7.32% |
Volatility
FBTAX vs. FHCCX - Volatility Comparison
Fidelity Advisor Biotechnology Fund Class A (FBTAX) has a higher volatility of 9.36% compared to Fidelity Advisor Health Care Fund Class C (FHCCX) at 7.07%. This indicates that FBTAX's price experiences larger fluctuations and is considered to be riskier than FHCCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FBTAX | FHCCX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.36% | 7.07% | +2.29% |
Volatility (6M)Calculated over the trailing 6-month period | 17.00% | 22.46% | -5.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.00% | 25.67% | +0.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.32% | 19.41% | +3.91% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.59% | 19.58% | +5.01% |